☰

Empresas y finanzas

Pfizer to buy Hospira for about $15 billion


    (Reuters) - Drugmaker Pfizer Inc said it would buy Hospira Inc for about $15 billion to gain access to its biosimilars.

    The offer of $90 per share represents a premium of 39 percent to HOSPIRA (HSP.NY)stock's close on Wednesday.

    The total enterprise value of the deal is about $17 billion, the companies said.

    (Reporting by Vidya L Nathan in Bengaluru; Editing by Don Sebastian)